Skip to main content
Market intelligence
UTHRHealthcare

United Therapeutics Corp insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 25, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 25, 2026Martine A RothblattChairperson & CEOSale9,500$550.40$5,228,772
Jun 24, 2026Martine A RothblattChairperson & CEOSale9,500$548.69$5,212,520
Jun 23, 2026Martine A RothblattChairperson & CEOSale9,500$543.95$5,167,571